Sexually transmitted diseases (STDs) remain a pressing public health concern, with millions of new infections recorded annually. While statistics for 2025 are not yet available, recent data ...
As total joint replacement surgical technology has improved over the past, but a vital part of care — infection prevention methods — have largely remained stagn ...
PHAXIAM Therapeutics (Euronext: PHXM - FR0011471135), a biopharmaceutical company developing innovative treatments for severe and resistant bacterial infections, today announces an update on its ...